Instrument Inactif

Cours Islet Sciences Inc OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04/05/15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23/04/15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24/03/15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09/03/15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05/03/15

Secteur

	Varia. 1 janv.	Capi.
IQVIA HOLDINGS INC.	+1,77%	42,75 Md
LONZA GROUP AG	+47,70%	41,61 Md
MODERNA, INC.	+12,24%	41,34 Md
CELLTRION, INC.	-8,83%	26,59 Md
ICON PUBLIC LIMITED COMPANY	+7,44%	25,49 Md
ALNYLAM PHARMACEUTICALS, INC.	-23,01%	18,12 Md
MEDPACE HOLDINGS, INC.	+30,56%	12,24 Md
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1,82%	11,76 Md
UNITED THERAPEUTICS CORPORATION	+8,35%	11 Md